NEW YORK (360Dx) – The Foundation for Innovative New Diagnostics (FIND) announced today that it has partnered with the nonprofit group Clinical Research Malaysia (CRM) to develop a new strategy for hepatitis C diagnosis.

FIND said it has signed a memorandum of understanding (MOU) to work with CRM to assess the use of rapid diagnostic tests (RDTs) in decentralized primary healthcare facilities in Malaysia. FIND added that it would provide technical assistance to the Malaysian Ministry of Health — which operates CRM — on the project.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the Firestone Institute for Respiratory Health at McMaster University developed a cellular and molecular phenotyping pipeline using archived samples of lung tissue derived from patients diagnosed with fibrotic interstitial lung disease. 


In this webinar, Dr. Matthew Faron, a pathologist from the Medical College of Wisconsin, will share results of a comparison study of three rapid influenza assays.


Sponsored by

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.

Sponsored by
Swift Biosciences

Sequencing workflows require library quantification and normalization to ensure data quality and reduce cost.